Practice Management News

The goal of a new EULAR initiative linking trial centers across Europe is quicker, more efficient clinical trials across the spectrum of rheumatic diseases, according to a speaker at the EULAR 2024 Congress.

As we enter the second half of 2024, it is important to understand some tax law changes that became effective this year and could affect your retirement savings and tax planning.

Caregivers of pediatric rheumatology patients transitioning to adult care reported a “lack of clear information” on the necessary procedures, according to data presented at the EULAR 2024 Congress.

The AMA House of Delegates adopted several new policies to promote public health at its annual meeting.

A new trial center network and two major data collection projects are among recent EULAR initiatives for improved care of patients with rheumatic and musculoskeletal diseases, according to a speaker at the EULAR 2024 Congress.

The AMA adopted new policies on broader Medicare and Medicaid health care coverage during its annual House of Delegates meeting.

The AMA announced a new policy that supports requirements for drug and device sponsors to develop diversity action plans so that women and sexual and gender minorities are adequately represented in their clinical trials.

The AMA House of Delegates adopted two new policies aiming to reform prior authorization and the burden it causes patients and physicians.

Biosimilars have generated billions of dollars of savings for the health care complex, but they have not had an impact on out-of-pocket expenses for patients with private insurance, according to findings published in JAMA Health Forum.

Pediatric rheumatology patients could be considered ready to transfer to adult care if they score greater than 4 on the Transition Readiness Assessment Questionnaire, according to data published in Rheumatology.